TreeWAS – Variant ID: rs10400317

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
L85.9 Epidermal thickening, unspecified	0.055	0.945	0.000
S83.2 Tear of meniscus, current	0.020	0.980	0.000
L85 Other epidermal thickening	0.019	0.981	0.000
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.018	0.982	0.000
S83.6 Sprain and strain of other and unspecified parts of knee	0.017	0.983	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.016	0.984	0.000
S83.4 Sprain and strain involving (fibular)(tibial) collateral ligamnent of knee	0.015	0.984	0.000
S83.3 Tear of articular cartilage of knee, current	0.015	0.985	0.000
S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee	0.014	0.986	0.000
L85.3 Xerosis cutis	0.014	0.986	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.014	0.986	0.000
L85.0 Acquired ichthyosis	0.014	0.986	0.000
S83.0 Dislocation of patella	0.013	0.987	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.013	0.987	0.000
S83.1 Dislocation of knee	0.012	0.988	0.000
H73.8 Other specified disorders of tympanic membrane	0.012	0.988	0.000
D86.0 Sarcoidosis of lung	0.000	0.988	0.012
T42.4 Benzodiazepines	0.011	0.989	0.000
S83.7 Injury to multiple structures of knee	0.011	0.989	0.000
R22.2 Localised swelling, mass and lump, trunk	0.010	0.990	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.010	0.990	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.010	0.990	0.000
Y42.7 Androgens and anabolic congeners	0.009	0.991	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.009	0.991	0.000
C50.2 Upper-inner quadrant of breast	0.000	0.991	0.009
Y42.5 Other oestrogens and progestogens	0.009	0.991	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
F32.1 Moderate depressive episode	0.008	0.992	0.000
F32 Depressive episode	0.008	0.992	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.992	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.008	0.992	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.008	0.992	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992	0.000
F32.8 Other depressive episodes	0.008	0.992	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.007	0.992	0.000
T42.2 Succinimides and oxazolidinediones	0.007	0.992	0.000
Y42.1 Thyroid hormones and substitutes	0.007	0.993	0.000
Y42.2 Antithyroid drugs	0.007	0.993	0.000
Y42.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.007	0.993	0.000
Y42.4 Oral contraceptives	0.007	0.993	0.000
T42.3 Barbiturates	0.007	0.993	0.000
T42.1 Iminostilbenes	0.007	0.993	0.000
H73 Other disorders of tympanic membrane	0.007	0.993	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.993	0.007
S82.30 Fracture of lower end of tibia (closed)	0.006	0.994	0.000
F32.0 Mild depressive episode	0.006	0.994	0.000
H73.1 Chronic myringitis	0.006	0.994	0.000
T42.0 Hydantoin derivatives	0.005	0.994	0.000
M19.90 Arthrosis, unspecified (Multiple sites)	0.006	0.994	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.005	0.995	0.000
D86 Sarcoidosis	0.000	0.995	0.005
D25.2 Subserosal leiomyoma of uterus	0.005	0.995	0.000
H53.0 Amblyopia ex anopsia	0.000	0.995	0.005
H73.0 Acute myringitis	0.005	0.995	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.995	0.005
H73.9 Disorder of tympanic membrane, unspecified	0.004	0.995	0.000
L85.8 Other specified epidermal thickening	0.004	0.996	0.000
R63.0 Anorexia	0.004	0.996	0.000
M25.78 Osteophyte (Other)	0.004	0.996	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.004	0.996	0.000
W02.9 Unspecified place	0.004	0.996	0.000
R63.5 Abnormal weight gain	0.004	0.996	0.000
T93 Sequelae of injuries of lower limb	0.004	0.996	0.000
F80.1 Expressive language disorder	0.000	0.996	0.004
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.996	0.004
M18.1 Other primary arthrosis of first carpometacarpal joint	0.004	0.996	0.000
M79.65 Pain in limb (Pelvic region and thigh)	0.004	0.996	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.004	0.996	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
Z43.1 Attention to gastrostomy	0.000	0.996	0.004
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.004	0.996	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.996	0.004
T93.2 Sequelae of other fractures of lower limb	0.004	0.996	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.996	0.004
D86.1 Sarcoidosis of lymph nodes	0.000	0.996	0.004
O03.4 Incomplete, without complication	0.000	0.996	0.004
G43.1 Migraine with aura [classical migraine]	0.004	0.996	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.004	0.996	0.000
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.000	0.996	0.004
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.003	0.996	0.000
D86.3 Sarcoidosis of skin	0.000	0.996	0.003
T93.0 Sequelae of open wound of lower limb	0.003	0.996	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.003	0.997	0.000
T78.2 Anaphylactic shock, unspecified	0.000	0.997	0.003
M54.94 Dorsalgia, unspecified (Thoracic region)	0.003	0.997	0.000
M54.9 Dorsalgia, unspecified	0.003	0.997	0.000
M18 Arthrosis of first carpometacarpal joint	0.003	0.997	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.997	0.003
L84 Corns and callosities	0.003	0.997	0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.003	0.997	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.003	0.997	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.003	0.997	0.000
T93.1 Sequelae of fracture of femur	0.003	0.997	0.000
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.003	0.997	0.000
N13.8 Other obstructive and reflux uropathy	0.003	0.997	0.000
S02.2 Fracture of nasal bones	0.000	0.997	0.003
G62.9 Polyneuropathy, unspecified	0.000	0.997	0.003
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.003	0.997	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.003	0.997	0.000
F45.8 Other somatoform disorders	0.003	0.997	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.997	0.003
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.003	0.997	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.003	0.997	0.000
M25.77 Osteophyte (Ankle and foot)	0.003	0.997	0.000
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.000	0.997	0.003
H44.2 Degenerative myopia	0.000	0.997	0.003
M25.84 Other specified joint disorders (Hand)	0.003	0.997	0.000
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.003	0.997	0.000
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.003	0.997	0.000
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.003	0.997	0.000
K22.8 Other specified diseases of oesophagus	0.003	0.997	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.997	0.003
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.003	0.997	0.000
N13 Obstructive and reflux uropathy	0.003	0.997	0.000
M25.71 Osteophyte (Shoulder region)	0.003	0.997	0.000
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.003	0.997	0.000
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.003	0.997	0.000
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.003	0.997	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.997	0.003
Z01.6 Radiological examination, not elsewhere classified	0.000	0.997	0.003
T45.4 Iron and its compounds	0.002	0.997	0.000
F80 Specific developmental disorders of speech and language	0.000	0.997	0.002
M54.92 Dorsalgia, unspecified (Cervical region)	0.002	0.997	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.997	0.003
M34.1 CR(E)ST syndrome	0.003	0.997	0.000
M25.82 Other specified joint disorders (Upper arm)	0.002	0.997	0.000
S02.21 Fracture of nasal bones (open)	0.000	0.997	0.002
M25.8 Other specified joint disorders	0.003	0.997	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.002	0.997	0.000
L94.9 Localised connective tissue disorder, unspecified	0.002	0.997	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
N13.6 Pyonephrosis	0.002	0.998	0.000
T59.8 Other specified gases, fumes and vapours	0.002	0.998	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.998	0.002
D80-D89 Certain disorders involving the immune mechanism	0.000	0.998	0.002
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.998	0.002
J31.2 Chronic pharyngitis	0.002	0.998	0.000
G43 Migraine	0.002	0.998	0.000
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.000	0.998	0.002
M25.83 Other specified joint disorders (Forearm)	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
C83.1 Small cleaved cell (diffuse)	0.000	0.998	0.002
L94.0 Localised scleroderma [morphea]	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
F43.2 Adjustment disorders	0.002	0.998	0.000
G43.9 Migraine, unspecified	0.002	0.998	0.000
G43.0 Migraine without aura [common migraine]	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
J30.4 Allergic rhinitis, unspecified	0.002	0.998	0.000
N13.4 Hydroureter	0.002	0.998	0.000
L94 Other localised connective tissue disorders	0.002	0.998	0.000
D89.3 Immune reconstitution syndrome	0.000	0.998	0.002
M25.87 Other specified joint disorders (Ankle and foot)	0.002	0.998	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.998	0.002
M25.7 Osteophyte	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
D89.1 Cryoglobulinaemia	0.000	0.998	0.002
F80.9 Developmental disorder of speech and language, unspecified	0.000	0.998	0.002
F80.8 Other developmental disorders of speech and language	0.000	0.998	0.002
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.000	0.998	0.002
F80.0 Specific speech articulation disorder	0.000	0.998	0.002
F81 Specific developmental disorders of scholastic skills	0.000	0.998	0.002
M25.88 Other specified joint disorders (Other)	0.002	0.998	0.000
M25.86 Other specified joint disorders (Lower leg)	0.002	0.998	0.000
N60.2 Fibroadenosis of breast	0.002	0.998	0.000
X62.9 Unspecified place	0.002	0.998	0.000
M25.89 Other specified joint disorders (Site unspecified)	0.002	0.998	0.000
M25.80 Other specified joint disorders (Multiple sites)	0.002	0.998	0.000
L94.8 Other specified localised connective tissue disorders	0.002	0.998	0.000
D83 Common variable immunodeficiency	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
C71.9 Brain, unspecified	0.000	0.998	0.002
F80.2 Receptive language disorder	0.000	0.998	0.002
T36.0 Penicillins	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
D81 Combined immunodeficiencies	0.000	0.998	0.002
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
G43.2 Status migrainosus	0.002	0.998	0.000
S32.30 Fracture of ilium (closed)	0.002	0.998	0.000
S90.9 Superficial injury of ankle and foot, unspecified	0.000	0.998	0.002
K26.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
T36.3 Macrolides	0.002	0.998	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.000	0.998	0.002
M34 Systemic sclerosis	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.002	0.998	0.000
G43.3 Complicated migraine	0.002	0.998	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.002	0.998	0.000
D83.9 Common variable immunodeficiency, unspecified	0.000	0.998	0.002
C83.7 Burkitt's tumour	0.000	0.998	0.002
C83.6 Undifferentiated (diffuse)	0.000	0.998	0.002
C83.4 Immunoblastic (diffuse)	0.000	0.998	0.002
C83.2 Mixed small and large cell (diffuse)	0.000	0.998	0.002
L94.2 Calcinosis cutis	0.002	0.998	0.000
M34.9 Systemic sclerosis, unspecified	0.002	0.998	0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.002	0.998	0.000
L94.6 Ainhum	0.002	0.998	0.000
L94.5 Poikiloderma vasculare atrophicans	0.002	0.998	0.000
L94.4 Gottron's papules	0.002	0.998	0.000
L94.3 Sclerodactyly	0.002	0.998	0.000
L94.1 Linear scleroderma	0.002	0.998	0.000
M34.8 Other forms of systemic sclerosis	0.002	0.998	0.000
M34.0 Progressive systemic sclerosis	0.002	0.998	0.000
T51.0 Ethanol	0.002	0.998	0.000
M25.70 Osteophyte (Multiple sites)	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
F81.8 Other developmental disorders of scholastic skills	0.000	0.998	0.002
F81.3 Mixed disorder of scholastic skills	0.000	0.998	0.002
F81.2 Specific disorder of arithmetical skills	0.000	0.998	0.002
F81.1 Specific spelling disorder	0.000	0.998	0.002
F81.0 Specific reading disorder	0.000	0.998	0.002
G62.8 Other specified polyneuropathies	0.000	0.998	0.002
D84 Other immunodeficiencies	0.000	0.998	0.002
R63.6 Insufficient intake of food and water due to self neglect	0.002	0.998	0.000
G62 Other polyneuropathies	0.000	0.998	0.002
R63 Symptoms and signs concerning food and fluid intake	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
M25.81 Other specified joint disorders (Shoulder region)	0.002	0.998	0.000
M54.99 Dorsalgia, unspecified (Site unspecified)	0.002	0.998	0.000
C83.0 Small cell (diffuse)	0.000	0.998	0.002
D83.8 Other common variable immunodeficiencies	0.000	0.998	0.002
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.998	0.002
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.998	0.002
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.998	0.002
H00.0 Hordeolum and other deep inflammation of eyelid	0.002	0.998	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.002	0.998	0.000
S82.3 Fracture of lower end of tibia	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Z92.8 Personal history of other medical treatment	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M25.79 Osteophyte (Site unspecified)	0.002	0.998	0.000
M25.73 Osteophyte (Forearm)	0.002	0.998	0.000
S12.10 Fracture of second cervical vertebra (closed)	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.000	0.998	0.002
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
Z98.2 Presence of cerebrospinal fluid drainage device	0.002	0.998	0.000
D82 Immunodeficiency associated with other major defects	0.000	0.998	0.001
F80-F89 Disorders of psychological development	0.000	0.998	0.002
D81.9 Combined immunodeficiency, unspecified	0.000	0.998	0.001
D81.8 Other combined immunodeficiencies	0.000	0.998	0.001
D81.7 Major histocompatibility complex class II deficiency	0.000	0.998	0.001
D81.6 Major histocompatibility complex class I deficiency	0.000	0.998	0.001
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.998	0.001
D81.4 Nezelof's syndrome	0.000	0.998	0.001
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.998	0.001
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.998	0.001
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.998	0.001
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.998	0.001
G43.8 Other migraine	0.002	0.998	0.000
M51.8 Other specified intervertebral disk disorders	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.000	0.998	0.002
W25.9 Unspecified place	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)	0.002	0.998	0.000
S52.20 Fracture of shaft of ulna (closed)	0.002	0.998	0.000
F60.9 Personality disorder, unspecified	0.002	0.998	0.000
M34.2 Systemic sclerosis induced by drugs and chemicals	0.002	0.998	0.000
T41.5 Therapeutic gases	0.001	0.998	0.000
T41.4 Anaesthetic, unspecified	0.001	0.998	0.000
T41.3 Local anaesthetics	0.001	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.001	0.998	0.000
T41.1 Intravenous anaesthetics	0.001	0.998	0.000
T41.0 Inhaled anaesthetics	0.001	0.998	0.000
Y60.4 During endoscopic examination	0.000	0.998	0.002
O35 Maternal care for known or suspected foetal abnormality and damage	0.000	0.998	0.002
T59 Toxic effect of other gases, fumes and vapours	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.002	0.998	0.000
F60 Specific personality disorders	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.000
W02.8 Other specified place	0.001	0.998	0.000
W02.3 Sports and athletics area	0.001	0.998	0.000
W02.7 Farm	0.001	0.998	0.000
W02.6 Industrial and construction area	0.001	0.998	0.000
W02.5 Trade and service area	0.001	0.998	0.000
W02.4 Street and highway	0.001	0.998	0.000
W02.2 School, other institution and public administrative area	0.001	0.998	0.000
W02.1 Residential institution	0.001	0.998	0.000
W02.0 Home	0.001	0.998	0.000
M25.72 Osteophyte (Upper arm)	0.002	0.998	0.000
T59.9 Gases, fumes and vapours, unspecified	0.002	0.998	0.000
V28.9 Unspecified motorcycle rider injured in traffic accident	0.002	0.998	0.000
N34.2 Other urethritis	0.002	0.998	0.000
S82.31 Fracture of lower end of tibia (open)	0.000	0.998	0.001
D84.1 Defects in the complement system	0.000	0.998	0.001
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.998	0.001
G62.2 Polyneuropathy due to other toxic agents	0.000	0.998	0.001
G62.1 Alcoholic polyneuropathy	0.000	0.998	0.001
H90.3 Sensorineural hearing loss, bilateral	0.002	0.998	0.000
R63.2 Polyphagia	0.001	0.998	0.000
T49.9 Topical agent, unspecified	0.001	0.998	0.000
T49.8 Other topical agents	0.001	0.998	0.000
T49.7 Dental drugs, topically applied	0.001	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.001	0.998	0.000
T49.2 Local astringents and local detergents	0.001	0.998	0.000
T49.1 Antipruritics	0.001	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.001	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
T78 Adverse effects, not elsewhere classified	0.000	0.998	0.002
G30.9 Alzheimer's disease, unspecified	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.998	0.000
T48.5 Anti-common-cold drugs	0.001	0.998	0.000
T48.4 Expectorants	0.001	0.998	0.000
T48.3 Antitussives	0.001	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.001	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.998	0.000
T48.0 Oxytocic drugs	0.001	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000
T37.5 Antiviral drugs	0.001	0.998	0.000
T37.4 Anthelminthics	0.001	0.998	0.000
T37.3 Other antiprotozoal drugs	0.001	0.998	0.000
T37.1 Antimycobacterial drugs	0.001	0.998	0.000
T37.0 Sulphonamides	0.001	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
F45 Somatoform disorders	0.002	0.998	0.000
S32.50 Fracture of pubis (closed)	0.002	0.998	0.000
F32.9 Depressive episode, unspecified	0.002	0.998	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.998	0.001
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.998	0.001
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.998	0.001
D82.2 Immunodeficiency with short-limbed stature	0.000	0.998	0.001
D82.0 Wiskott-Aldrich syndrome	0.000	0.998	0.001
F60.6 Anxious [avoidant] personality disorder	0.001	0.998	0.000
L81.4 Other melanin hyperpigmentation	0.000	0.998	0.002
M92.6 Juvenile osteochondrosis of tarsus	0.000	0.998	0.001
S32.3 Fracture of ilium	0.001	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.001	0.998	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.998	0.001
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.998	0.000
F89 Unspecified disorder of psychological development	0.000	0.998	0.001
F88 Other disorders of psychological development	0.000	0.998	0.001
F83 Mixed specific developmental disorders	0.000	0.998	0.001
F82 Specific developmental disorder of motor function	0.000	0.998	0.001
S32.00 Fracture of lumbar vertebra (closed)	0.001	0.998	0.000
F60.0 Paranoid personality disorder	0.001	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.001	0.998	0.000
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.000	0.998	0.001
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.001	0.998	0.000
D84.8 Other specified immunodeficiencies	0.000	0.999	0.001
J38.4 Oedema of larynx	0.001	0.999	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
F45.0 Somatisation disorder	0.001	0.999	0.000
F60.4 Histrionic personality disorder	0.001	0.999	0.000
F60.1 Schizoid personality disorder	0.001	0.999	0.000
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures	0.000	0.999	0.001
O35.6 Maternal care for (suspected) damage to foetus by radiation	0.000	0.999	0.001
O35.5 Maternal care for (suspected) damage to foetus by drugs	0.000	0.999	0.001
O35.4 Maternal care for (suspected) damage to foetus from alcohol	0.000	0.999	0.001
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother	0.000	0.999	0.001
O35.2 Maternal care for (suspected) hereditary disease in foetus	0.000	0.999	0.001
T43.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
T59.7 Carbon dioxide	0.001	0.999	0.000
T59.6 Hydrogen sulphide	0.001	0.999	0.000
T59.5 Fluorine gas and hydrogen fluoride	0.001	0.999	0.000
T59.4 Chlorine gas	0.001	0.999	0.000
T59.3 Lachrymogenic gas	0.001	0.999	0.000
T59.2 Formaldehyde	0.001	0.999	0.000
T59.1 Sulphur dioxide	0.001	0.999	0.000
T59.0 Nitrogen oxides	0.001	0.999	0.000
D84.9 Immunodeficiency, unspecified	0.000	0.999	0.001
H69.9 Eustachian tube disorder, unspecified	0.001	0.999	0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.000	0.999	0.001
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.999	0.000
W02.31 Fall involving ice-skates, skis, roller-skates or skateboards; Sports and athletics area; While engaged in leisure activity	0.001	0.999	0.000
W02.30 Fall involving ice-skates, skis, roller-skates or skateboards; Sports and athletics area; While engaged in sports activity	0.001	0.999	0.000
W02.81 Fall involving ice-skates, skis, roller-skates or skateboards; Other specified places; While engaged in leisure activity	0.001	0.999	0.000
N48.0 Leukoplakia of penis	0.000	0.999	0.001
T38.5 Other oestrogens and progestogens	0.001	0.999	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.001	0.999	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.001	0.999	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.001	0.999	0.000
F60.2 Dissocial personality disorder	0.001	0.999	0.000
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.001	0.999	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.999	0.001
F45.9 Somatoform disorder, unspecified	0.001	0.999	0.000
F60.5 Anankastic personality disorder	0.001	0.999	0.000
T38.9 Other and unspecified hormone antagonists	0.001	0.999	0.000
T38.7 Androgens and anabolic congeners	0.001	0.999	0.000
T38.4 Oral contraceptives	0.001	0.999	0.000
T38.2 Antithyroid drugs	0.001	0.999	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.999	0.001
A69.9 Spirochaetal infection, unspecified	0.000	0.999	0.001
D82.1 Di George's syndrome	0.000	0.999	0.001
F45.1 Undifferentiated somatoform disorder	0.001	0.999	0.000
G62.0 Drug-induced polyneuropathy	0.000	0.999	0.001
K70.4 Alcoholic hepatic failure	0.001	0.999	0.000
N03.9 Unspecified	0.001	0.999	0.000
T43.9 Psychotropic drug, unspecified	0.001	0.999	0.000
F45.2 Hypochondriacal disorder	0.001	0.999	0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.000	0.999	0.001
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.000	0.999	0.001
T40.2 Other opioids	0.001	0.999	0.000
S32.31 Fracture of ilium (open)	0.001	0.999	0.000
A87.9 Viral meningitis, unspecified	0.000	0.999	0.001
T37.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.999	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.001	0.999	0.000
T40.8 Lysergide [LSD]	0.001	0.999	0.000
T40.7 Cannabis (derivatives)	0.001	0.999	0.000
T40.3 Methadone	0.001	0.999	0.000
T40.0 Opium	0.001	0.999	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.999	0.001
F60.7 Dependent personality disorder	0.001	0.999	0.000
I82.2 Embolism and thrombosis of vena cava	0.000	0.999	0.001
J98.8 Other specified respiratory disorders	0.000	0.999	0.001
T38.0 Glucocorticoids and synthetic analogues	0.001	0.999	0.000
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.5 Other antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
Y60.5 During heart catheterisation	0.000	0.999	0.001
D80 Immunodeficiency with predominantly antibody defects	0.000	0.999	0.001
H60.1 Cellulitis of external ear	0.000	0.999	0.001
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
M25.75 Osteophyte (Pelvic region and thigh)	0.001	0.999	0.000
N93.0 Postcoital and contact bleeding	0.000	0.999	0.001
Q87.4 Marfan's syndrome	0.001	0.999	0.000
S32.5 Fracture of pubis	0.001	0.999	0.000
T40.1 Heroin	0.001	0.999	0.000
T43.2 Other and unspecified antidepressants	0.001	0.999	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
T46.7 Peripheral vasodilators	0.001	0.999	0.000
T78.9 Adverse effect, unspecified	0.000	0.999	0.001
Y83.4 Other reconstructive surgery	0.001	0.999	0.000
F84 Pervasive developmental disorders	0.000	0.999	0.001
C22.9 Liver, unspecified	0.000	0.999	0.001
E07.9 Disorder of thyroid, unspecified	0.000	0.999	0.001
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.000	0.999	0.001
S32.0 Fracture of lumbar vertebra	0.001	0.999	0.000
H72 Perforation of tympanic membrane	0.001	0.999	0.000
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
C44.9 Malignant neoplasm of skin, unspecified	0.001	0.999	0.000
F45.4 Persistent somatoform pain disorder	0.001	0.999	0.000
H04.1 Other disorders of lachrymal gland	0.000	0.999	0.001
H72.9 Perforation of tympanic membrane, unspecified	0.001	0.999	0.000
I82.9 Embolism and thrombosis of unspecified vein	0.000	0.999	0.001
J94.8 Other specified pleural conditions	0.001	0.999	0.000
S69.9 Unspecified injury of wrist and hand	0.001	0.999	0.000
T38.1 Thyroid hormones and substitutes	0.001	0.999	0.000
T40.5 Cocaine	0.001	0.999	0.000
T75.4 Effects of electric current	0.001	0.999	0.000
I31.9 Disease of pericardium, unspecified	0.001	0.999	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.999	0.000
G37 Other demyelinating diseases of central nervous system	0.000	0.999	0.001
N03.1 Focal and segmental glomerular lesions	0.001	0.999	0.000
S12.1 Fracture of second cervical vertebra	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations